165 related articles for article (PubMed ID: 15537650)
1. Glycan-independent role of calnexin in the intracellular retention of Charcot-Marie-tooth 1A Gas3/PMP22 mutants.
Fontanini A; Chies R; Snapp EL; Ferrarini M; Fabrizi GM; Brancolini C
J Biol Chem; 2005 Jan; 280(3):2378-87. PubMed ID: 15537650
[TBL] [Abstract][Full Text] [Related]
2. Exposure at the cell surface is required for gas3/PMP22 To regulate both cell death and cell spreading: implication for the Charcot-Marie-Tooth type 1A and Dejerine-Sottas diseases.
Brancolini C; Edomi P; Marzinotto S; Schneider C
Mol Biol Cell; 2000 Sep; 11(9):2901-14. PubMed ID: 10982389
[TBL] [Abstract][Full Text] [Related]
3. Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.
Hara T; Hashimoto Y; Akuzawa T; Hirai R; Kobayashi H; Sato K
Sci Rep; 2014 Nov; 4():6992. PubMed ID: 25385046
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of a new member of the gas3/PMP22 gene family in C. elegans.
Agostoni E; Gobessi S; Brancolini C; Schneider C
Gene; 1999 Jul; 234(2):267-74. PubMed ID: 10395899
[TBL] [Abstract][Full Text] [Related]
6. Sequence of human GAS3/PMP22 full-length cDNA.
Edomi P; Martinotti A; Colombo MP; Schneider C
Gene; 1993 Apr; 126(2):289-90. PubMed ID: 8482547
[TBL] [Abstract][Full Text] [Related]
7. Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.
Vanoye CG; Sakakura M; Follis RM; Trevisan AJ; Narayan M; Li J; Sanders CR; Carter BD
J Biol Chem; 2019 Aug; 294(32):12054-12065. PubMed ID: 31213528
[TBL] [Abstract][Full Text] [Related]
8. Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22.
Chies R; Nobbio L; Edomi P; Schenone A; Schneider C; Brancolini C
J Cell Sci; 2003 Mar; 116(Pt 6):987-99. PubMed ID: 12584243
[TBL] [Abstract][Full Text] [Related]
9. Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.
Fabbretti E; Edomi P; Brancolini C; Schneider C
Genes Dev; 1995 Aug; 9(15):1846-56. PubMed ID: 7649472
[TBL] [Abstract][Full Text] [Related]
10. Overloaded endoplasmic reticulum-Golgi compartments, a possible pathomechanism of peripheral neuropathies caused by mutations of the peripheral myelin protein PMP22.
D'Urso D; Prior R; Greiner-Petter R; Gabreëls-Festen AA; Müller HW
J Neurosci; 1998 Jan; 18(2):731-40. PubMed ID: 9425015
[TBL] [Abstract][Full Text] [Related]
11. Rho-dependent regulation of cell spreading by the tetraspan membrane protein Gas3/PMP22.
Brancolini C; Marzinotto S; Edomi P; Agostoni E; Fiorentini C; Müller HW; Schneider C
Mol Biol Cell; 1999 Jul; 10(7):2441-59. PubMed ID: 10397775
[TBL] [Abstract][Full Text] [Related]
12. Direct relationship between increased expression and mistrafficking of the Charcot-Marie-Tooth-associated protein PMP22.
Marinko JT; Carter BD; Sanders CR
J Biol Chem; 2020 Aug; 295(34):11963-11970. PubMed ID: 32647009
[TBL] [Abstract][Full Text] [Related]
13. Peripheral myelin protein-22 expression in Charcot-Marie-Tooth disease type 1a sural nerve biopsies.
Hanemann CO; Stoll G; D'Urso D; Fricke W; Martin JJ; Van Broeckhoven C; Mancardi GL; Bartke I; Müller HW
J Neurosci Res; 1994 Apr; 37(5):654-9. PubMed ID: 8028042
[TBL] [Abstract][Full Text] [Related]
14. Ultrastructural distribution of PMP22 in Charcot-Marie-Tooth disease type 1A.
Haney C; Snipes GJ; Shooter EM; Suter U; Garcia C; Griffin JW; Trapp BD
J Neuropathol Exp Neurol; 1996 Mar; 55(3):290-9. PubMed ID: 8786387
[TBL] [Abstract][Full Text] [Related]
15. Mutations of peripheral myelin protein 22 result in defective trafficking through mechanisms which may be common to diseases involving tetraspan membrane proteins.
Sanders CR; Ismail-Beigi F; McEnery MW
Biochemistry; 2001 Aug; 40(32):9453-9. PubMed ID: 11583144
[TBL] [Abstract][Full Text] [Related]
16. Elevated Peripheral Myelin Protein 22, Reduced Mitotic Potential, and Proteasome Impairment in Dermal Fibroblasts from Charcot-Marie-Tooth Disease Type 1A Patients.
Lee S; Bazick H; Chittoor-Vinod V; Al Salihi MO; Xia G; Notterpek L
Am J Pathol; 2018 Mar; 188(3):728-738. PubMed ID: 29246495
[TBL] [Abstract][Full Text] [Related]
17. Impaired intracellular trafficking is a common disease mechanism of PMP22 point mutations in peripheral neuropathies.
Naef R; Suter U
Neurobiol Dis; 1999 Feb; 6(1):1-14. PubMed ID: 10078969
[TBL] [Abstract][Full Text] [Related]
18. Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbs.
Hanemann CO; Gabreëls-Festen AA; Stoll G; Müller HW
Acta Neuropathol; 1997 Oct; 94(4):310-5. PubMed ID: 9341930
[TBL] [Abstract][Full Text] [Related]
19. Genetic epidemiology of Charcot-Marie-Tooth disease.
Braathen GJ
Acta Neurol Scand Suppl; 2012; (193):iv-22. PubMed ID: 23106488
[TBL] [Abstract][Full Text] [Related]
20. Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22.
Marinko JT; Wright MT; Schlebach JP; Clowes KR; Heintzman DR; Plate L; Sanders CR
J Biol Chem; 2021; 296():100719. PubMed ID: 33933451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
